Medtech

FDA
In September 2018 a leap forward in treating burn victims was made with the approval of Avita Medical’s RECELL Autologous Cell Harvesting Device. The Food and Drug Administration (FDA) green lit the California-based company’s burn treatment device that uses a small amount of a patient’s own skin to prepare what is called Spray-On Skin Cells.
Researchers with the University of California San Francisco (UCSF) developed a “neural decoder” that translates brain activity to synthesize audible speech. They published their research in the journal Nature.
FDA
Biom’up announced that the U.S. Food and Drug Administration approved the IDE application for HEMOSNOW, a hemostatic dry powder made from porcine collagen and bovine-derived chondroitin sulfate developed by the Company for managing minimal and mild levels of bleeding during surgical procedures.
Possibly in response to a trend for Medicare-for-All initiatives, healthcare stocks plunged this week. This largely affected companies like UnitedHealth, which fell 3.2%, Anthem, dropping by 6.8%, and Cigna Corp., sliding 5.1%.
The life science industry is continually making advancements in every area! We want to know what cool science innovations are currently in progress and the professionals behind them.
Major framework agreement signed with Life Healthcare Distribution (“LHC”) for the exclusive distribution of HEMOBLAST Bellows in the sizeable and growing Australian market
The San Francisco Business Times came out with a list of 64 major Bay Area employers and their median pay, which they then compared to their chief executives’ annual compensation.
The biopharma and medtech ecosystem in New Hampshire is growing thanks, in part, to state-supported tax exemptions and an increasing number of regenerative medicine manufacturing companies setting up shop in the Granite State.
Bionovate Technologies, Corp. announced that during the last fiscal year’s reporting period, it acquired a patent from Ramot University in Tel Aviv, Israel as part of the company’s strategy to develop non-invasive cancer imaging and identification systems.
Have you ever considered relocating for your career? If you have, you aren’t alone. According to a recent BioSpace Community Survey, 78% of life science professionals would be open to relocation for the right job opportunity.
PRESS RELEASES